Fidelity, Biogen, Sanofi Join $45M Bet on Alzheimer's and Parkinson's Startup
Feb 10, 2016, 10:05 AM
by
Michael Croft
Forbes | The drug industry is pouring billions into R&D against Alzheimer's disease. Yet many people in the business will tell you not nearly enough is known about the underlying biology.
February 10, 2016 | The drug industry is pouring billions into R&D against Alzheimer's disease. Yet many people in the business will tell you not nearly enough is known about the underlying biology. Forbes